Similar to the results from the EGFRΔEgr2 folliculitis model, topical JAK1/2 inhibition re-established skin barrier function, restored visible hair growth and reduced MHC expression on the treated side (right side) of the mice (Fig. 5I,J). This evidence concerns the gene JAK1 and folliculitis.